These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2846096)

  • 1. Virus removal or inactivation in hemoglobin solutions by ultrafiltration or detergent/solvent treatment.
    Bechtel MK; Bagdasarian A; Olson WP; Estep TN
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):123-8. PubMed ID: 2846096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus inactivation in hemoglobin solutions by heat.
    Estep TN; Bechtel MK; Miller TJ; Bagdasarian A
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):129-34. PubMed ID: 2846097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.
    Edwards CA; Piet MP; Chin S; Horowitz B
    Vox Sang; 1987; 52(1-2):53-9. PubMed ID: 3111089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate.
    Highsmith F; Xue H; Chen X; Benade L; Owens J; Shanbrom E; Drohan W
    Blood; 1995 Jul; 86(2):791-6. PubMed ID: 7606009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration.
    Troccoli NM; McIver J; Losikoff A; Poiley J
    Biologicals; 1998 Dec; 26(4):321-9. PubMed ID: 10403036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of viruses (human immunodeficiency, hepatitis B, vesicular stomatitis and Sindbis viruses) from an intravenous immunoglobulin preparation.
    Hamamoto Y; Harada S; Yamamoto N; Uemura Y; Goto T; Suyama T
    Vox Sang; 1987; 53(2):65-9. PubMed ID: 2825431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment.
    Seitz H; Blümel J; Schmidt I; Willkommen H; Löwer J
    Biologicals; 2002 Sep; 30(3):197-205. PubMed ID: 12217344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments.
    Chandra S; Cavanaugh JE; Lin CM; Pierre-Jerome C; Yerram N; Weeks R; Flanigan E; Feldman F
    Transfusion; 1999 Mar; 39(3):249-57. PubMed ID: 10204586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus safety of solvent/detergent-treated antihaemophilic factor concentrate.
    Horowitz MS; Rooks C; Horowitz B; Hilgartner MW
    Lancet; 1988 Jul; 2(8604):186-9. PubMed ID: 2899662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of protein kinase C inhibitors on viral entry and infectivity.
    Constantinescu SN; Cernescu CD; Popescu LM
    FEBS Lett; 1991 Nov; 292(1-2):31-3. PubMed ID: 1659999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
    Prince AM; Horowitz B; Brotman B
    Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
    Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
    Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
    Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies.
    Johnston A; Uren E; Johnstone D; Wu J
    Biologicals; 2003 Sep; 31(3):213-21. PubMed ID: 12935811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution.
    Dichtelmüller H; Rudnick D; Kloft M
    Biologicals; 2002 Jun; 30(2):135-42. PubMed ID: 12127315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stability in drinking and surface water of nine virus species from different genera (author's transl)].
    Mahnel H; Ottis K; Herlyn M
    Zentralbl Bakteriol Orig B; 1977 Jan; 164(1-2):64-84. PubMed ID: 14460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations.
    Horowitz B; Wiebe ME; Lippin A; Stryker MH
    Transfusion; 1985; 25(6):516-22. PubMed ID: 3934801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus removal studies using nanofiltration membranes.
    O'Grady J; Losikoff A; Poiley J; Fickett D; Oliver C
    Dev Biol Stand; 1996; 88():319-26. PubMed ID: 9119156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products.
    Roberts P
    Biologicals; 2000 Mar; 28(1):29-32. PubMed ID: 10799053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new resuscitation fluid "stabilized hemoglobin" preparation and characteristics.
    Iwashita Y; Yabuki A; Yamaji K; Iwasaki K; Okami T; Hirata C; Kosaka K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):271-80. PubMed ID: 3179469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.